Wikidata

(Q73806740)

English

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protoco

scientific article published on 01 May 2000

In more languages
default for all languages
No label defined

No description defined

Statements

title
Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10817549
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10817549%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q73806740&oldid=1756384170"